Ben Askew

Partner at Xontogeny LLC

Ben Askew

Ben Askew

Partner at Xontogeny LLC

Biography

Blueprint Medicines
Scientific Advisory Board
Ben Askew joined Third Rock Ventures in 2011 as an Entrepreneur-in-Residence after more than 20 years serving in senior research positions in the biotechnology and pharmaceutical industries. Ben specializes in building high functioning medicinal chemistry organizations, designing selective kinase inhibitors and developing drugs against GPCRs, nuclear receptors, integrin antagonists and protease inhibitors. In 2005, Ben joined the EMD Serono Research Institute, where he most recently served as Vice President of Research, Global Head of New Chemical Entities (NCE) Technologies. Prior to joining Serono, Ben held escalating positions of seniority at Amgen and Merck. He holds a B.A. from Gannon University and a Ph.D. in Chemistry from the University of Pittsburgh.

Overview
RelSci Relationships

85

Number of Boards

3

Contact Data
Trying to get in touch with Ben Askew? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Ben Askew likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chairman & Chief Executive Officer at Xontogeny LLC

Relationship likelihood: Strong

Co-Founder at AsclepiX Therapeutics LLC

Relationship likelihood: Strong

President & Chief Executive Officer at Arvinas, Inc.

Relationship likelihood: Strong

Advisor Partner at Flagship Pioneering

Relationship likelihood: Strong

Founding Partner at Synergy Partners R&D Solutions

Relationship likelihood: Strong

Co-Founder at Allied Minds Plc

Relationship likelihood: Strong

Chief Scientific Officer at Agios Pharmaceuticals, Inc.

Relationship likelihood: Strong

Former Partner at Choate Hall & Stewart LLP

Relationship likelihood: Strong

Co-Founder & CSO at AsclepiX Therapeutics LLC

Relationship likelihood: Average

Managing Partner at Barer & Son Capital LLC

Relationship likelihood: Average

Paths to Ben Askew
Potential Connections via
Relationship Science
You
Ben Askew
Partner at Xontogeny LLC
Education

Higher Education (Enrollment 4,444). Gannon is a Catholic, Diocesan University offering a comprehensive, values-centered learning experience that emphasizes faith, leadership, inclusiveness and social responsibility. Our faculty and staff prepare students to be global citizens.

The University of Pittsburgh is among the nation's oldest and most distinguished comprehensive universities, with a wide variety of high-quality programs in the arts and sciences as well as professional fields. Pitt is a member of the Association of American Universities (AAU), which comprises 62 preeminent doctorate-granting research institutions in North America

Career History
Research & Development, Venture
Current

Founded in 1999, Perceptive Advisors focuses on supporting progress in the life sciences industry by identifying opportunities and directing financial resources toward the most promising technologies in modern healthcare. Today, the firm manages approximately $7.3 billion across our strategies.

Partner
2019 - Current

Xontogeny LLC operates biotech aggregator company. The firm offers entrepreneurs with guidance and operational support in drug and technology development. The company was founded by Christopher Nishan Garabedian and is headquartered in Boston, MA.

Entrepreneur-in-Residence
2011 - Prior

Third Rock Ventures invests in companies located in the US. The firm targets operating in the fields of healthcare sector. It provides financing for early-stage capital requirements. It also acts as a lead investor.

Boards & Committees
Member of Scientific Advisory Board
Prior

Blueprint Medicines Corp. is a precision therapy company. It focuses on medicines to improve the lives of patients with genomically defined cancers, rare diseases and cancer immunotherapy. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Ben Askew. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Ben Askew's profile does not indicate a business or promotional relationship of any kind between RelSci and Ben Askew.